Toggle navigation
Home
Search
Services
Blog
Contact
About
Phase 1 Multiple-Dose Safety, Pharmacokinetic, and Drug Interaction of DIM
Search grants from
Share this grant:
:
:
Abstract
Funding
Related projects
Comments
Recent in Grantomics:
Your institution
vs. funders. Who wins?
Read more...
How should you pick the next fundable research topic?
Read more...
Recently viewed grants:
Structural Mechanisms of Ebola Virus RNA Synthesis
Prestera Center's Technology Assisted Care (TAC).
Increasing Prevention, Care, and Treatment of HIV/AIDS Through Support
Allergy and Immunology
Environmental Quality of Sediments by Bioassay
Recently added grants:
Novel Statistical Methods for Multi-omics Data Integration in Alzheimer's Disease
Elucidating the Spatiotemporal Regulation of a Long Non-Coding RNA Required for Neurodevelopment
Close the GAP: Glycemic control after Antenatal corticosteroids in women with Pregestational diabetes
Neurodevelopmental Emergence of Callous-Unemotional Behavior Beginning in Infancy: Neural Markers and Environmental Risk and Protective Factors
Acute Use of Alcohol and Attentional Bias towards Suicide: An Experimental Test of the Attention-Allocation Model.
Abstract
Funding Agency
Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Research and Development Contracts (N01)
Project #
N01CN35008-12-0-1
Application #
7577651
Study Section
Project Start
2003-02-18
Project End
2008-02-17
Budget Start
Budget End
Support Year
Fiscal Year
2007
Total Cost
Indirect Cost
Related projects
NIH 2008
N01 CA
Phase 1 Multiple-Dose Safety, Pharmacokinetic, and Drug Interaction of DIM
/
$57,513
NIH 2007
N01 CA
Phase 1 Multiple-Dose Safety, Pharmacokinetic, and Drug Interaction Clinical Stu
Hurwityz, Daniel /
$64,187
NIH 2007
N01 CA
Phase 1 Multiple-Dose Safety, Pharmacokinetic, and Drug Interaction of DIM
/
Comments
Be the first to comment on this grant